Grown Rogue International (GRUSF) Cash & Current Investments (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Cash & Current Investments of $13.7 million for Q1 2026, up 106.32% year-over-year from $6.6 million in Q1 2025, and up 20.48% quarter-over-quarter from $11.4 million in Q4 2025.
Grown Rogue International (GRUSF) Cash & Current Investments (2009 - 2026) Analysis & Trends
Grown Rogue International's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $13.7 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 106.32% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (up 106.32% YoY), while the FY2025 annual figure was $11.4 million, up 239.28% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $13.7 million, up from $11.4 million in the prior quarter.
- The five-year high for Cash & Current Investments was $13094.1 billion in Q3 2025, with the low at $1.1 million in Q1 2022.
- The 5-year median for Cash & Current Investments is $5.2 million (2023), against an average of $1091.2 billion.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 32.94% in 2024, then surged 319443814.64% in 2025.
- Grown Rogue International's Cash & Current Investments stood at $1.2 million in 2022, then soared by 319.53% to $5.0 million in 2023, then sank by 32.94% to $3.4 million in 2024, then surged by 239.28% to $11.4 million in 2025, then rose by 20.48% to $13.7 million in 2026.
- Business Quant data shows GRUSF's Cash & Current Investments at $13.7 million in Q1 2026, $11.4 million in Q4 2025, and $13094.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | Grown Rogue International | 113.47 Mn | 101.93 Mn | 5.37 Mn | 11.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.54 Mn |
| Mar 31, 2026 | 13.70 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 13,094.09 Bn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Jul 31, 2023 | 6.36 Mn |
| Jan 31, 2023 | 3.49 Mn |
| Oct 31, 2022 | 1.19 Mn |
| Jan 31, 2022 | 1.11 Mn |
| Jul 31, 2021 | 217,788.00 |
| Apr 30, 2021 | 1.72 Mn |
| Jan 31, 2021 | 1.28 Mn |
| Oct 31, 2020 | 217,788.00 |
| Jul 31, 2020 | 591,352.00 |
| Apr 30, 2020 | 599,391.00 |
| Jan 31, 2020 | 133,646.00 |